Company: NCEL
Filing Date: 2025-10-24
Form Type: POS AM
Source: 0001213900-25-102149
Chunk: 66

Company: NewcelX Ltd.
Filing Date: 2025-10-24
Form: POS AM
Chunk 66
---
 and settlement
amounts actually and reasonably incurred in a civil or criminal action, suit or proceeding by reason of having been the representative
of, or serving at the request of, the corporation.

Subject to Swiss law, our
articles of association provide for indemnification of the existing and former members of our board of directors, senior management, and
their heirs, executors and administrators, against liabilities arising in connection with the performance of their duties in such capacity,
and permit us to advance the expenses of defending any act, suit or proceeding to members of our board of directors and senior management.

In addition, under general
principles of Swiss employment law, an employer may be required to indemnify an employee against losses and expenses incurred by such
employee in the proper execution of his or her duties under the employment agreement with the Company.

We have entered into indemnification
agreements with each of the members of our board of directors and senior management in the form to be filed as an exhibit to this registration
statement upon the completion of this offering. We have also obtained directors’ and officers’ liability insurance to cover
certain actions undertaken by our board of directors and senior management.

Insofar as indemnification
for liabilities arising under the Securities Act of 1933, as amended, or the Securities Act, may be permitted to directors, officers and
controlling persons of the Company, the Company has been advised that, in the opinion of the Securities and Exchange Commission, such
indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable.

Item 7. Recent Sales of Unregistered Securities

Set forth below are the
sales of all securities by the Company since October 2022, which were not registered under the Securities Act. The Company believes that
each of such issuances was exempt from registration under the Securities Act in reliance on Sections 3(a)(9) and 4(a)(2) of the Securities
Act and/or Regulation S under the Securities Act.

Since October 2022, we
have granted to our directors, consultants and service providers, officers, and employees options to purchase an aggregate of 52,742
Common Shares under our Share Option Plan Regulation 2021, with an exercise prices ranging between $17.44 and $54.40 per share. As of
October 22, 2025, no options granted to directors, officers and employees were exercised, and 20,740 options forfeited, such that the